NSUN6 Antibody
Novus Biologicals, part of Bio-Techne | Catalog # NBP2-85405
Key Product Details
Species Reactivity
Human
Applications
Western Blot
Label
Unconjugated
Antibody Source
Polyclonal Rabbit
Concentration
0.5 mg/ml
Product Specifications
Immunogen
The immunogen is a synthetic peptide directed towards the N-terminal region of human NSUN6. Peptide sequence: SIFPKISLRPEVENYLKEGFMNKEIVTALGKQEAERKFETLLKHLSHPPS The peptide sequence for this immunogen was taken from within the described region.
Clonality
Polyclonal
Host
Rabbit
Scientific Data Images for NSUN6 Antibody
![Western Blot: NSUN6 Antibody [NBP2-85405]](https://resources.bio-techne.com/images/products/NSUN6-Antibody-Western-Blot-NBP2-85405-img0001.jpg "Western Blot: NSUN6 Antibody [NBP2-85405]")
Western Blot: NSUN6 Antibody [NBP2-85405]
Western Blot: NSUN6 Antibody [NBP2-85405] - WB Suggested Anti-NSUN6 Antibody Titration: 0.2-1 ug/ml. Positive Control: Human muscleApplications for NSUN6 Antibody
Application
Recommended Usage
Western Blot
1.0 ug/ml
Formulation, Preparation, and Storage
Purification
Affinity purified
Formulation
PBS, 2% Sucrose
Preservative
0.09% Sodium Azide
Concentration
0.5 mg/ml
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C short term. Aliquot and store at -20C long term. Avoid freeze-thaw cycles.
Background: NSUN6
Alternate Names
EC 2.1.1, EC 2.1.1.-, EC 2.1.1.52, FLJ23743, NOL1/NOP2/Sun and PUA domain-containing protein 1, NOL1/NOP2/Sun domain family 6, NOL1/NOP2/Sun domain family member 6, NOL1/NOP2/Sun domain family, member 6, NOP2/Sun domain family, member 6,4933414E04Rik, NOPD1, nucleolar protein (NOL1/NOP2/sun) and PUA domains 1, putative methyltransferase NSUN6
Gene Symbol
NSUN6
Additional NSUN6 Products
Product Specific Notices for NSUN6 Antibody
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...